{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:12:28Z","timestamp":1784999548593,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Cerebra Foundation for the Brain Injured Child","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Instituto de Salud Carlos III, European Regional Development Fund \"A way of doing Europe","award":["PI22\/00109"],"award-info":[{"award-number":["PI22\/00109"]}]},{"name":"Instituto de Salud Carlos III, European Regional Development Fund \"A way of doing Europe\"","award":["PI17\/01350"],"award-info":[{"award-number":["PI17\/01350"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,1,31]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pre-eclampsia affects ~5%\u20137%\u2009of pregnancies. Although improved obstetric care has significantly diminished its associated maternal mortality, it remains a leading cause of maternal morbidity and mortality in the world. Term pre-eclampsia accounts for 70% of all cases and a large proportion of maternal\u2013fetal morbidity related to this condition. Unlike in preterm pre-eclampsia, the prediction and prevention of term pre-eclampsia remain unsolved. Previously proposed approaches are based on combined third-trimester screening and\/or prophylactic drugs, but these policies are unlikely to be widely implementable in many world settings. Recent evidence shows that the soluble fms-like tyrosine kinase-1 (s-Flt-1) to placental growth factor (PlGF) ratio measured at 35\u201337\u2009weeks\u2019 gestation predicts term pre-eclampsia with an 80% detection rate. Likewise, recent studies demonstrate that induction of labour beyond 37\u2009weeks is safe and well accepted by women. We hypothesise that a single-step universal screening for term pre-eclampsia based on sFlt1\/PlGF ratio at 35\u201337\u2009weeks followed by planned delivery beyond 37\u2009weeks reduces the prevalence of term pre-eclampsia without increasing the caesarean section rates or worsening the neonatal outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>We propose an open-label randomised clinical trial to evaluate the impact of a screening of term pre-eclampsia with the sFlt-1\/PlGF ratio followed by planned delivery in asymptomatic nulliparous women at 35\u201337\u2009weeks. Women will be assigned 1:1 to revealed (sFlt-1\/PlGF known to clinicians) versus concealed (unknown) arms. A cut-off of &gt;90th centile is used to define the high risk of subsequent pre-eclampsia and offer planned delivery from 37\u2009weeks. The efficacy variables will be analysed and compared between groups primarily following an intention-to-treat approach, by ORs and their 95% CI. This value will be computed using a Generalised Linear Mixed Model for binary response (study group as fixed effect and the centre as intercept random effect).<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study is conducted under the principles of Good Clinical Practice. This study was accepted by the Clinical Research Ethics Committee of Hospital Clinic Barcelona on 20 November 2020. Subsequent approval by individual ethical committees and competent authorities was granted. The study results will be published in peer-reviewed journals and disseminated at international conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"NCT04766866\">NCT04766866<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076201","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T10:44:02Z","timestamp":1717325042000},"page":"e076201","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Multicentre randomised trial of screening with sFlt1\/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"isrctn04766866","registry":"10.18810\/isrctn"}],"author":[{"given":"Elisa","family":"Llurba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Crispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-7411","authenticated-orcid":false,"given":"Francesca","family":"Crovetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Krofta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Mackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Martinez-Varea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-0763","authenticated-orcid":false,"given":"Albert","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Paya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Chantraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina","family":"Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kajdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"Lopez-Tinajero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4403-1274","authenticated-orcid":false,"given":"Francesc","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gratacos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"2024060203032710000_14.3.e076201.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.02.010"},{"key":"2024060203032710000_14.3.e076201.2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70227-X"},{"key":"2024060203032710000_14.3.e076201.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38629.587639.7C"},{"key":"2024060203032710000_14.3.e076201.4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0002-9378(98)70544-7","article-title":"The preterm prediction study: recurrence risk of spontaneous preterm birth","volume":"178","author":"Iams","year":"1998","journal-title":"Am J Obstetri Gynecolo"},{"key":"2024060203032710000_14.3.e076201.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2010.10.010"},{"key":"2024060203032710000_14.3.e076201.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3093"},{"key":"2024060203032710000_14.3.e076201.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.08.019"},{"key":"2024060203032710000_14.3.e076201.8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/14767058.2018.1500551","article-title":"Preeclampsia: risk factors and neonatal outcomes associated with early- versus late-onset diseases","volume":"33","author":"Weitzner","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024060203032710000_14.3.e076201.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60279-6"},{"key":"2024060203032710000_14.3.e076201.10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/GCO.0000000000000419","article-title":"Cardiovascular origins of preeclampsia","volume":"29","author":"Kalafat","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.11","doi-asserted-by":"crossref","unstructured":"Kornacki J , Wirstlein P , Wender-Ozegowska E . n.d. Markers of endothelial injury and dysfunction in early- and late-onset preeclampsia. Life;10:239. doi:10.3390\/life10100239","DOI":"10.3390\/life10100239"},{"key":"2024060203032710000_14.3.e076201.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.08.019"},{"key":"2024060203032710000_14.3.e076201.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559"},{"key":"2024060203032710000_14.3.e076201.14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin versus placebo in pregnancies at high risk of term preeclampsia","volume":"144","author":"D\u00f6bert","year":"2021","journal-title":"Circulation"},{"key":"2024060203032710000_14.3.e076201.15","article-title":"Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term","volume":"1","author":"Cluver","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2024060203032710000_14.3.e076201.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800566"},{"key":"2024060203032710000_14.3.e076201.17","article-title":"Induction of labour at or beyond 37 weeks' gestation","volume":"7","author":"Middleton","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024060203032710000_14.3.e076201.18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/uog.15879","article-title":"First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction","volume":"48","author":"Crovetto","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ajog.2015.11.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks\u2019 gestation","volume":"214","author":"Gallo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.20","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00043.2008"},{"key":"2024060203032710000_14.3.e076201.21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","article-title":"Angiogenic factors in Preeclampsia: from diagnosis to therapy","volume":"67","author":"Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"2024060203032710000_14.3.e076201.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838"},{"key":"2024060203032710000_14.3.e076201.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003215"},{"key":"2024060203032710000_14.3.e076201.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"key":"2024060203032710000_14.3.e076201.25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/uog.15663","article-title":"Biophysical and biochemical markers at 35-37 weeks\u2019 gestation in the prediction of adverse perinatal outcome","volume":"47","author":"Vali\u00f1o","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/uog.24789","article-title":"STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks\u2019 gestation","volume":"59","author":"D\u00f6bert","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.27","unstructured":"Samplesize4Clinicaltrials: sample size calculation for the comparison of means or proportions in phase III clinical trials; Clinical trial design"},{"key":"2024060203032710000_14.3.e076201.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2006.12.015"},{"key":"2024060203032710000_14.3.e076201.29","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5315"},{"key":"2024060203032710000_14.3.e076201.30","doi-asserted-by":"publisher","DOI":"10.1515\/jpme.1990.18.3.165"},{"key":"2024060203032710000_14.3.e076201.31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21563"},{"key":"2024060203032710000_14.3.e076201.32","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318168c4a4"},{"key":"2024060203032710000_14.3.e076201.33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-12-84","article-title":"The Vermont Oxford neonatal encephalopathy registry: rationale, methods, and initial results","volume":"12","author":"Pfister","year":"2012","journal-title":"BMC Pediatr"},{"key":"2024060203032710000_14.3.e076201.34","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000149131.72248.E6"},{"key":"2024060203032710000_14.3.e076201.35","doi-asserted-by":"crossref","unstructured":"Spielberger CD . State-trait anxiety inventory. In: The Corsini Encyclopedia of Psychology. John Wiley & Sons Ltd, 2010: 1. doi:10.1002\/9780470479216","DOI":"10.1002\/9780470479216.corpsy0943"},{"key":"2024060203032710000_14.3.e076201.36","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.145"},{"key":"2024060203032710000_14.3.e076201.37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/nur.4770100503","article-title":"The labour agentry scale: psychometric properties of an instrument measuring control during childbirth","volume":"10","author":"Hodnett","year":"1987","journal-title":"Res Nurs Health"},{"key":"2024060203032710000_14.3.e076201.38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/uog.14815","article-title":"Maternal Subclinical vascular changes in fetal growth restriction with and without pre-Eclampsia - PubMed","volume":"46","author":"Stergiotou","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2024060203032710000_14.3.e076201.39","unstructured":"EMA . ICH E9 statistical principles for clinical trials - scientific guideline. European Medicines Agency; 2018. Available: https:\/\/www.ema.europa.eu\/en\/ich-e9-statistical-principles-clinical-trials-scientific-guideline [Accessed 3 Jan 2023]."},{"key":"2024060203032710000_14.3.e076201.40","unstructured":"EMA . Missing data in confirmatory clinical trials - scientific guideline. European Medicines Agency; 2018. Available: https:\/\/www.ema.europa.eu\/en\/missing-data-confirmatory-clinical-trials-scientific-guideline"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T10:44:22Z","timestamp":1717325062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,8]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-076201"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076201","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}